RSLS - ReShape Lifesciences rises after 1-for-50 reverse stock split announcement
- Health solutions company ReShape Lifesciences ( NASDAQ: RSLS ) rose by 4.20% after the company said its board has declared a 1-for-50 reverse stock split, effective from the commencement of trading on Dec. 23.
- Any fractional shares resulting from the reverse stock split is expected to be rounded up to the nearest whole share.
- RSLS has also increased the number of shares authorized for issue under its certificate of incorporation to 300M shares.
- The company's shareholders have approved the reverse stock split and increase in authorized shares at the Dec. 14 annual meeting.
- The new CUSIP number for shares following the reverse stock split will be 76090R200.
- Source: Press Release
For further details see:
ReShape Lifesciences rises after 1-for-50 reverse stock split announcement